Putnam Global Health Care Fund is a registered fund series of Putnam Global Health Care Fund (series S000005666). Net assets $1.5B as of 2026-05-31.
Showing 15 of 115 holdings by value.
| Holding | Ticker | Value | % of fund |
|---|---|---|---|
| Eli Lilly & Co. | — | $192.5M | 1314.59% |
| Johnson & Johnson | — | $124.0M | 846.49% |
| UnitedHealth Group, Inc. | — | $101.5M | 693.29% |
| AbbVie, Inc. | — | $88.6M | 604.94% |
| Novartis AG | — | $75.2M | 513.31% |
| Merck & Co., Inc. | — | $71.5M | 488.01% |
| AstraZeneca plc | — | $68.4M | 467.25% |
| Thermo Fisher Scientific, Inc. | — | $65.9M | 450.26% |
| Intuitive Surgical, Inc. | — | $59.2M | 404.04% |
| Sanofi SA | — | $47.4M | 323.48% |
| Edwards Lifesciences Corp. | — | $41.1M | 280.35% |
| Roche Holding AG | — | $40.9M | 279.13% |
| CVS Health Corp. | — | $40.1M | 273.54% |
| Gilead Sciences, Inc. | — | $38.4M | 262.54% |
| McKesson Corp. | — | $31.4M | 214.15% |
| Report date | Net assets |
|---|---|
| 2026-05-31 | $1.5B |
| 2026-02-28 | $1.6B |
| 2025-11-30 | $1.6B |
| 2025-08-31 | $1.5B |
| 2025-05-31 | $1.4B |
| 2025-02-28 | $1.7B |
| 2024-11-30 | $1.8B |
| 2024-08-31 | $1.9B |